Endologix to Participate in Two Investor Conferences in February

Go back to Endologix to Participate in Two Investor Conferences in February

Endologix (ELGX) Complelling Ahead of H216 Catalysts, but Risks Remain - BTIG

February 23, 2016 11:09 AM EST

BTIG affirmed its Buy rating and $14 price target on Endologix (Nasdaq: ELGX) following the company reported Q4 results late... More

Endologix (ELGX) Misses Q4 EPS by 6c

February 22, 2016 4:06 PM EST

Endologix (NASDAQ: ELGX) reported Q4 EPS of ($0.22), $0.06 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $39.2 million versus the consensus estimate of $39.97 million.

For earnings history and earnings-related data on Endologix (ELGX) click here.

... More